FDA Approval Archives - Metastatic Breast Cancer Trial Talk

FDA Approval

FDA Approves MARGENZA™

On December 16, 2020, the FDA approved margetuximab-cmkb (MARGENZA™) in combination with chemotherapy, for treating metastatic HER2-positive breast cancer.

Read More

SEARCH OUR SITE

for past articles or specific information.